Hospice News August 18, 2021
Post-acute tech company Element5 has secured $15 Million in Series A funds. The company will invest these dollars in expanding the reach of its robotic process automation (RPA) and artificial intelligence solution. The Series A fund raises the company’s total capital raised to $18.5 million.
Series A funding is typically a company’s first significant round of outreach to potential investors, often private equity or venture capital firms. For Element5 the lead investor is the venture capital group Insight Partners, with additional participation from Maxwell Investment Partners.
“Post-acute and hospice is its own beast. Insight has a track record in our space, and they understand the nuances,” Element5 CEO Joe Randesi told Hospice News. “We wanted a strategic partner that can...
Today's Sponsors
Today's Sponsor